Medication
Drug Class: SGLT2 inhibitors
Small molecule
Mechanism of Action of Empagliflozin
INN: Empagliflozin · Pharmacological Reference Profile
- Biological Target Sodium-glucose cotransporter 2 (SGLT2)
- Drug Class SGLT2 inhibitors
- Physiological System Urinary System
- Molecular Modality Small molecule
How Empagliflozin Works
BIOCHEMICAL TARGET PATHWAY
Empagliflozin → [ Sodium-glucose cotransporter 2 (SGLT2) ] → Clinical Effector Response
Detailed pharmacological mechanism under curation.
REGISTERED FORMULATIONS
Commercial Brands (7)
Jardiance
Glyxambi
Synjardy
Trijardy
(as a combination product containing Empagliflozin
Linagliptin
and Metformin)